Literature DB >> 11937767

Clinical and subclinical reactivation of genital herpes virus.

Manfred H Wolff1, Judith Schmitt, Markus Rahaus, Hans Dudda, Wolfgang Hatzmann.   

Abstract

Reactivations of herpes simplex virus (HSV) either symptomatically (recrudescence) or without symptoms (recurrence) are well documented. As an asymptomatic reactivation may contribute to transmitting HSV to potential acceptors the frequency of reactivations should be evaluated. In order to evaluate the frequency of HSV-2 reactivation 173 genital swabs of a group of women chosen at random were analyzed by nested PCR. 34 (19.6%) showed clinical evidence of a herpes infection, 77 (44.5%) had no symptoms at all and 62 (35.8%) had other symptoms. In 26 (15%) HSV-DNA was detected. 11 (38.4%) could be characterized as asymptomatic reactivations. Typing of the HSV-positive swabs resulted in 11 HSV-2 and 10 HSV-1 strains. Additionally 18 HSV-positive swabs of the oral cavity resulted in 15 (83.2%) HSV-1 and 3 (16.4%) HSV-2 strains. The results of typing indicate a change of HSV-1 and HSV-2 epidemiology. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937767     DOI: 10.1159/000050083

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  5 in total

1.  Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998.

Authors:  W Hellenbrand; W Thierfelder; B Müller-Pebody; O Hamouda; T Breuer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

2.  Oral shedding of herpes simplex virus type 2.

Authors:  A Wald; M Ericsson; E Krantz; S Selke; L Corey
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

3.  Relaxed repression of herpes simplex virus type 1 genomes in Murine trigeminal neurons.

Authors:  Tracy Terry-Allison; Colton A Smith; Neal A DeLuca
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

4.  Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?

Authors:  S Buxbaum; M Geers; G Gross; H Schöfer; H F Rabenau; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2003-05-22       Impact factor: 3.402

5.  Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality.

Authors:  Bobbie Ann Austin; Cassandra M James; Peter Härle; Daniel J J Carr
Journal:  Biol Proced Online       Date:  2006-06-14       Impact factor: 3.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.